Cancer patients can connect and be supported by others fighting the disease with a free patient navigation app.
A treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success in less common cancers.
Henry Ford Health System received an anonymous $20 million gift that will fund the Henry Ford Pancreatic Cancer Center, the tentative name for a global consortium of researchers that will seek to develop better methods for earlier detection of the disease.
Coffee can cause cancer? Many coffee drinkers are skeptical about the California judge's recent ruling on labeling cancer warnings on coffee purchased in the state.
A network of Chicago-area providers are working together to address cancer patients' needs beyond just healthcare services.
The CMS will now cover diagnostic laboratory tests using gene sequencing technology for Medicare cancer patients. The agency said the tests can help patients and their oncologists make better treatment decisions.
Cancer specialists are urging physicians and patients to consider testing for gene mutations tied to prostate cancer, though questions linger about its cost-effectiveness.
A new study published in JAMA Surgery finds that addressing racial health disparities requires better cultural competency among medical researchers as well as healthcare providers.
The U.S. Preventive Services Task Force is discouraging ovarian cancer screening for asymptomatic women, saying it's ineffective and has a high incidence of false-positives and doesn't curb mortality rates.
UCLA Health rethought its approach to how it sends patients FIT kits, an at-home test patients can take to screen for colon cancer.
First Descents' mission is to provide outdoor experiences free for 18- to 39-year olds diagnosed with cancer. The weeklong and multiday adventure experiences include activities like whitewater kayaking, rock climbing and surfing.
Tempus, Eric Lefkofsky's startup that's tackling cancer treatment with big data, just got a major boost in the data department. The Chicago-based company and a partner are getting access to CancerLinQ, a database of treatment results developed by the American Society of Clinical Oncology.